MedPath

ARBORVITAE HEALTH AND WELLBEING PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

6

TGA:6

Drug Approvals

Arborvitae ModeX (407405)

Product Name
Arborvitae ModeX
Approval Date
Apr 6, 2023
TGA

Arborvitae Joint Health (307151)

Product Name
Arborvitae Joint Health
Approval Date
Jul 18, 2018
TGA

Arborvitae Health and Wellbeing Supplement (280123)

Product Name
Arborvitae Health and Wellbeing Supplement
Approval Date
Sep 9, 2016
TGA

Arborvitae for Kids (278106)

Product Name
Arborvitae for Kids
Approval Date
Jul 22, 2016
TGA

Arborvitae Cognitive Function, Memory and Eye Health (277987)

Product Name
Arborvitae Cognitive Function, Memory and Eye Health
Approval Date
Jul 20, 2016
TGA

Arborvitae Teenagers Immune Boost and Concentration Supplement (277979)

Product Name
Arborvitae Teenagers Immune Boost and Concentration Supplement
Approval Date
Jul 20, 2016
TGA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.